Quest Diagnostics Inc (NYSE:DGX)
$ 136.94 0 (0%) Market Cap: 15.21 Bil Enterprise Value: 20.09 Bil PE Ratio: 18.43 PB Ratio: 2.36 GF Score: 84/100

Quest Diagnostics Inc at UBS Global Healthcare Conference Transcript

May 21, 2019 / 06:30PM GMT
Release Date Price: $97.77 (+0.71%)
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

Good afternoon, everybody. I'm Kevin Caliendo, the healthcare IT and supply chain analyst here at UBS, and we are very happy to have Steve Rusckowski, the CEO -- President, CEO and Chairman of Quest Diagnostics with us today.

Steve, thank you very much for coming. I don't know if you want to give a couple of minutes and talk a little bit about where the business is right now.

Stephen H. Rusckowski
Quest Diagnostics Incorporated - Former Executive Chairman

Sure, sure. We're going through an interesting transition. I'm sure we'll get a few questions from the audience on this. And this is the transition we think that has never been seen before in our industry, where really there's 3 changes that are happening. One is we're having the worst cut we've ever had from Medicare. And that was put in place with a bill called PAMA. Some of you that follow us know about that. And our math says it's going to take out around half the profit in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot